Data / Form D filings / Koios Medical, Inc.
Koios Medical, Inc.: Form D filings
Koios Medical, Inc., a biotechnology company in New York, NY, filed 7 Form D notices with the SEC between 2019 and 2025. The latest, on December 23, 2025, reports an offering of no set size with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 242 W. 38TH STREET, 14TH FLOOR, New York, NY, 10018
- Phone
- (732) 529-5755
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1764417
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Jun 24, 2024 | Amendment | $500,000 | $170,000 | $330,000 | 4 | May 17, 2024 | sec.gov |
| May 28, 2024 | New notice | $500,000,000 | $130,000,000 | $370,000,000 | 4 | May 17, 2024 | sec.gov |
| Feb 17, 2023 | New notice | $12,000,000 | $7,999,996 | $4,000,004 | 1 | Feb 3, 2023 | sec.gov |
| Aug 8, 2022 | New notice | $5,000,000 | $2,598,156 | $2,401,844 | 25 | Nov 16, 2021 | sec.gov |
| Feb 3, 2021 | New notice | $3,000,000 | $280,000 | $2,720,000 | 7 | Jan 26, 2021 | sec.gov |
| Jan 11, 2019 | New notice | $11,000,000 | $5,000,000 | $6,000,000 | 1 | Dec 28, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CHRISTINE CHAD LI | Director | |
| GREGORY CHAD MORAN | Director | |
| ROBERT CHAD MCCLENNAN | Executive Officer, Promoter | |
| GRAHAM ANDERSON | Executive Officer, Promoter | |
| MARK CHAD GLASGOLD | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Dec 22, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Koios Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.